Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administration of Natalizumab for Treatment of Relapsing-remitting Multiple Sclerosis (RRMS)
Biogen-sponsored study leveraging EU MS registry data to assess the incidence of anti-natalizumab antibodies in relapsing-remitting multiple…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Medication Understanding in MS
A University of Nottingham study titled 'Medication Understanding in MS' is listed for multiple sclerosis and is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple Sclerosis [NA]
Completed clinical trial evaluating extracorporeal shock wave therapy to improve sensitivity and postural stability in people with Multiple …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
This clinical trial update summarizes the real-world experience of participants treated with BRIUMVI (ublituximab-xiiy) for Relapsing Multip…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update for LY3541860 in adults with relapsing multiple sclerosis; the study is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2026-04-07Clinical Trial Update: Evaluation of a Self-management Program to Prevent Falls in People With Multiple Sclerosis [NA]
A completed clinical trial evaluating a self-management program to prevent falls in people with Multiple Sclerosis.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis [NA]
This clinical trial investigates whether the EXOPULSE Suit improves walking ability in people with multiple sclerosis; the study is currentl…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Computerized Cognitive Training in MS [NA]
A completed update on a clinical trial evaluating computerized cognitive training in people with multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS) [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating precision, biomarker-guided combination therapies for multiple sclerosis, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques [Phase 2]
This Phase 2 trial update describes a study sponsored by NINDS evaluating the effect of corticosteroids on inflammation at the edge of acute…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study Evaluating the Effect of BRIUMVI® (Ublituximab) on Pregnancy and Infant Outcomes in Participants With Multiple Sclerosis (MS)
This clinical trial update describes a study evaluating the effect of BRIUMVI (ublituximab) on pregnancy and infant outcomes in people with …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Effectiveness of TMS on Spasticity and Balance for Patients With MS [NA]
A clinical trial is evaluating the effectiveness of transcranial magnetic stimulation (TMS) on spasticity and balance in patients with multi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis [Phase 2]
Phase 2 clinical trial update investigating hyperpolarized carbon metabolic imaging as a biomarker in multiple sclerosis, currently not yet …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Evaluating the Feasibility and Effectiveness of an Online Psychological Intervention Targeting Problem-Solving and Coping Strategies in People With Multiple Sclerosis [NA]
A completed clinical trial evaluated the feasibility and effectiveness of an online psychological intervention targeting problem-solving and…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis [NA]
This clinical trial investigates whether internal- or external-focused exercise training, performed together with a cognitive task, can impr…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Sonification Techniques for Gait Training [NA]
A clinical trial sponsored by Istituti Clinici Scientifici Maugeri SpA is recruiting participants to evaluate sonification techniques for ga…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Classification of Upper and Lower Limb Spasticity Patterns and Their Impact on Quality of Life in Patients With Multiple Sclerosis
This clinical trial investigates patterns of upper and lower limb spasticity in people with multiple sclerosis and how these patterns affect…
-
FDA approval · 2026-04-01FDA Approved: KESIMPTA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for Kesimpta (ofatumumab) by Novartis Pharmaceuticals Corporation. This approval indicates an up…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis
A clinical trial update assessing the measurement properties of the Walking Adaptability Ladder Test and the Foot Tap Test in people with mu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
A non-interventional study sponsored by Novartis is evaluating whether serum neurofilament levels can prognosticate disease activity and gui…
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: ETNA-MS Device Validation Study
The ETNA-MS device validation study sponsored by Innodem Neurosciences has completed for multiple sclerosis.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
A Umeå University-led clinical trial is evaluating remote neuropsychological assessments for patients with various neurological conditions. …
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: Development of Digital Biomarkers in Multiple Sclerosis: Validation Study 2
A clinical trial evaluating digital biomarkers for multiple sclerosis has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
A completed clinical trial evaluated whether eye-movement measurements reflect disease severity and cognitive function in people with multip…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
This completed study in multiple sclerosis evaluates eye-tracking metrics as potential clinical measures.